Plasma Interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasian

被引：0
|
作者：
Cardellini, M.
Andreozzi, F.
Marini, M. A.
Laratta, E.
Perticone, M.
Mancuso, M. R.
Succurro, E.
Sciacqua, A.
Hribal, M. L.
Sesti, G.
机构：
[1] Univ Roma Tor Vergata, Rome, Italy
[2] Univ Magna Graecia, Catanzaro, Italy
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81452-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [31] PREVALENCE, DIAGNOSIS, AND TREATMENT OF IMPAIRED FASTING GLUCOSE AND IMPAIRED GLUCOSE TOLERANCE
    Karve, Amrita M.
    Hayward, Rodney
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [32] Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
    Kanat, Mustafa
    Mari, Andrea
    Norton, Luke
    Whinier, Diedre
    DeFronzo, Ralph A.
    Jenkinson, Chris
    Abdul-Ghani, Muhammad A.
    DIABETES, 2012, 61 (02) : 447 - 453
  • [33] Impaired fasting glucose and impaired glucose tolerance in urban population in India
    Ramachandran, A
    Snehalatha, C
    Satyavani, K
    Vijay, V
    DIABETIC MEDICINE, 2003, 20 (03) : 220 - 224
  • [34] Metabolic syndrome in individuals with impaired fasting glucose and impaired glucose tolerance
    Timar, RZ
    Serban, V
    Vlad, AR
    Diaconu, LF
    Rosu, M
    Olari, O
    Sima, AC
    DIABETOLOGIA, 2004, 47 : A109 - A109
  • [35] Plasma levels of von Willebrand factor in subjects with isolated impaired fasting glucose
    Coban, Erkan
    Bostan, Feyzi
    MEDICAL SCIENCE MONITOR, 2009, 15 (04): : CR194 - CR197
  • [36] Impaired Insulin Secretion Predicts Impaired. Glucose Tolerance and/or Impaired Fasting Glucose
    Onishi, Yukiko
    Hayashi, Tomoshige
    Sato, Kyoko K.
    Ki-Kuchi, Masatoshi
    Fujimoto, Wilfred Y.
    DIABETES, 2009, 58 : A578 - A578
  • [37] Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
    Pixner, Thomas
    Chaikouskaya, Tatsiana
    Lauth, Wanda
    Zimmermann, Georg
    Moerwald, Katharina
    Lischka, Julia
    Furthner, Dieter
    Awender, Elisabeth
    Geiersberger, Sabine
    Maruszczak, Katharina
    Forslund, Anders
    Anderwald, Christian-Heinz
    Cadamuro, Janne
    Weghuber, Daniel
    Bergsten, Peter
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [38] Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance.
    Marek Straczkowski
    Irina Kowalska
    Agnieszka Nikolajuk
    Stella Dzienis-Straczkowska
    Malgorzata Szelachowska
    Ida Kinalska
    Cardiovascular Diabetology, 2
  • [39] Effects of n-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance
    Derosa, Giuseppe
    Cicero, Arrigo F. G.
    D'Angelo, Angela
    Borghi, Claudio
    Maffioli, Pamela
    BIOFACTORS, 2016, 42 (03) : 316 - 322
  • [40] Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population
    Guerrero-Romero, Fernando
    Violante, Rafael
    Rodriguez-Moran, Martha
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2009, 23 (04) : 363 - 369
12345